Health Catalyst Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Health Catalyst has a total shareholder equity of $357.0M and total debt of $228.8M, which brings its debt-to-equity ratio to 64.1%. Its total assets and total liabilities are $691.7M and $334.7M respectively.
Belangrijke informatie
64.1%
Verhouding schuld/eigen vermogen
US$228.79m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$308.26m |
| Aandelen | US$357.00m |
| Totaal verplichtingen | US$334.72m |
| Totaal activa | US$691.72m |
Recente financiële gezondheidsupdates
Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27
Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Recent updates
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Dec 06Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Oct 14Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer
Sep 07Analyse van de financiële positie
Kortlopende schulden: HCAT's short term assets ($376.1M) exceed its short term liabilities ($318.0M).
Langlopende schulden: HCAT's short term assets ($376.1M) exceed its long term liabilities ($16.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: HCAT has more cash than its total debt.
Schuld verminderen: HCAT's debt to equity ratio has reduced from 173.7% to 64.1% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: HCAT has sufficient cash runway for more than 3 years based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if HCAT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.